Janusz Rybakowski

Education and Qualifications:
 medical graduate - 1969, Medical Academy, Poznan
 specialization - 1972, psychiatry, 1st degree
 doctoral thesis - 1973, Medical Academy, Poznan
 specialization - 1975, psychiatry, 2 nd degree
 postdoctoral thesis -1980, Medical Academy, Poznan
 professor in psychiatry - 1990, Medical Academy, Bydgoszcz
 professor in psychiatry - 1994, Poznan University of Medical Sciences

Professional Employment:
1969-1970, Residency, Medical Academy, Poznan
1970-1976, Research Assistant, Department of Psychiatry, Medical Academy, Poznan
1976-1977, NIH Fogarty Research Fellow, Department of Psychiatry, University of Pennsylvania, Philadelphia
1978-1984, Lecturer, Associate Professor, Department of Psychiatry, Medical Academy, Poznan
1985-1995, Chairman, Department of Psychiatry, Medical Academy, Bydgoszcz
1994- Head, Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan

Society Membership:
Polish Psychiatric Association (President 1998-2001, Chief, Psychopharmacology Section 2004-)
Association of European Psychiatrists (Board Member, 1998-2004, Fellow Member, 2002-)
Polish Academy of Sciences (Member of Neurobiology Committee, 1999-)
International Neuropsychiatric Association (Member of International Committee, 1999-)
European College of Neuro-Psychopharmacology, 1988- (Fellow Member, 2012-)
New York Academy of Sciences, 1993-
Society of Biological Psychiatry, 2000-
International Group for the Study of Lithium-Treated Patients (IGSLI), 2000-
International Society of Bipolar Disorders, 2001- (Board of Councillors Member 2003-2006)
International Society of Psychiatric Genetics, 2002-
Collegium Internationale Neuro-Psychopharmacologicum (CINP), 2003-
International Society of Affective Disorders (fellow since 2004)
European Group for the Research in Schizophrenia (EGRIS), 2005-

Editioral Board:
Polish:
Psychiatria Polska (President of the Board, 2000-)

Editor-in-Chief:
Farmakoterapia w Psychiatrii i Neurologii (Pharmacotherapy in Psychiatry and Neurology), 2006-
Neuropsychiatria i Neuropsychologia (Neuropsychiatry and Neuropsychology), 2006-

International:
Lithium (1990-1994)
Neuropsychobiology 1996-
Bipolar Disorders 2000-
Pharmacopsychiatry 2000-
Acta Neuropsychiatrica 2001- 2005
International Journal of Psychiatry in Clinical Practice 2005-
Cardiovascular Psychiatry and Neurology 2008-
World Journal of Biological Psychiatry, Field Editor, 2009-
Depression Research and Treatment, 2009-
Current Psychiatry Reports, 2011-
Clinical Neuropsychiatry, 2011-

Awards:
1992 – Individual award of Polish Ministry of Health for scientific publications
2002 – Award of Polish Ministry of Health (together with Prof. Joanna Hauser) for molecular-genetic studies in schizophrenia
2002 – Award of Newsweek Poland for the Department of Adult Psychiatry, Poznan, for the best psychiatric inpatient clinic in Poland
2012 – Lifetime Achievement Award of European Bipolar Forum for research on bipolar disorder

Publications:
1. About 500 publications (journal articles, book chapters)
Main topics: psychopharmacology, biological psychiatry, clinical psychiatry
Scopus Hirsch index (March 2013): 33, number of citations: 3994.
2. Books
Psychotropic drugs in the prophylaxis of affective illness and schizophrenia
(in Polish), 1995
Faces of Manic-Depressive Illness (in Polish), 2008
Faces of Manic-Depressive Illness (in English), 2009
Lexicon of mania and depression (together with Jan Jaracz, in Polish), 2010
3. Translations of books:
Biological basis of psychiatric disorders (A.Frazer, A.Winokur), 1982
Lithium treatment of manic-depressive illness (M.Schou), 1994

Most Cited Publications:
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
RS Kahn, WW Fleischhacker, H Boter, M Davidson, Y Vergouwe, ...
The Lancet 371 (9618), 1085-1097 2008

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
I Pacchiarotti, DJ Bond, RJ Baldessarini, WA Nolen, H Grunze, RW Licht, ...
American Journal of Psychiatry 170 (11), 1249-1262 2013

Indicators of immune activation in major depression
A Sluzewska, J Rybakowski, E Bosmans, M Sobieska, R Berghmans, ...
Psychiatry research 64 (3), 161-167 1996

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of …
M Bauer, PC Whybrow, J Angst, M Versiani, HJ Moeller, ...
The World Journal of Biological Psychiatry 3 (1), 5-43 2002

Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST)
M Davidson, S Galderisi, M Weiser, N Werbeloff, WW Fleischhacker, ...
American Journal of Psychiatry 166 (6), 675-682 2009

Interleukin‐6 serum levels in depressed patients before and after treatment with fluoxetine
A Służewska, JK Rybakowski, M Laciak, A Mackiewicz, M Sobieska, ...
Annals of the New York Academy of Sciences 762 (1), 474-476 1995

Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a …
S Kasper, G Hajak, K Wulff, WJG Hoogendijk, AL Montejo, E Smeraldi, ...
The Journal of clinical psychiatry 71 (2), 109-120 2010

Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group
DP Hibar, LT Westlye, NT Doan, N Jahanshad, JW Cheung, CRK Ching, ...
Molecular psychiatry 23 (4), 932-942 2018